Today the FDA approved the first targeted therapy to treat patients with a painful complication of sickle cell disease called vaso-occlusive crisis https://go.usa.gov/xpKhr   pic.twitter.com/uSfKXE0haC

Today the FDA approved the first targeted therapy to treat patients with a painful complication of sickle cell disease called vaso-occlusive crisis https://go.usa.gov/xpKhr  pic.twitter.com/uSfKXE0haC
Source: Food and Drug Adminstration (FDA): CDRHNew - Category: Medical Devices Authors: Source Type: news